Open access
159
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES
Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report
Fenge Li1 Department of Oncology, Tianjin Beichen HospitalTianjinPeople’s Republic of China;2 Core Laboratory, Tianjin Beichen Hospital, Tianjin, People’s Republic of China
https://orcid.org/0000-0003-3666-010XView further author information
Yupeng Wang1 Department of Oncology, Tianjin Beichen HospitalTianjinPeople’s Republic of ChinaView further author information
, Jin Yan1 Department of Oncology, Tianjin Beichen HospitalTianjinPeople’s Republic of ChinaView further author information
, Huancheng Wu3 Department of Neurosurgery, Tianjin Beichen Hospital, Tianjin, People’s Republic of China
https://orcid.org/0000-0002-5455-8646View further author information
Xueming Du1 Department of Oncology, Tianjin Beichen HospitalTianjinPeople’s Republic of ChinaView further author information
, Weihong Feng1 Department of Oncology, Tianjin Beichen HospitalTianjinPeople’s Republic of ChinaView further author information
, Xiaoqing Zhang4 Department of Basic Research, Suzhou Lanma Biotechnology Co, Suzhou, People’s Republic of ChinaView further author information
, Yongming Xue4 Department of Basic Research, Suzhou Lanma Biotechnology Co, Suzhou, People’s Republic of ChinaView further author information
, Huaqing Wang5 Department of Oncology, Tianjin Union Medical Center, Tianjin, People’s Republic of China;6 Department of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Wenxin Liu7 Department of Gynecological Oncology, Tianjin Medical Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 31-39
|
Received 26 Oct 2023, Accepted 28 Dec 2023, Published online: 08 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.